U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H39FO5
Molecular Weight 474.6047
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLUOCORTOLONE CAPROATE

SMILES

[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)CCCCC)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C

InChI

InChIKey=WHZRCUIISKRTJL-YTZKRAOUSA-N
InChI=1S/C28H39FO5/c1-5-6-7-8-24(33)34-15-23(32)25-16(2)11-19-18-13-21(29)20-12-17(30)9-10-27(20,3)26(18)22(31)14-28(19,25)4/h9-10,12,16,18-19,21-22,25-26,31H,5-8,11,13-15H2,1-4H3/t16-,18+,19+,21+,22+,25-,26-,27+,28+/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including http://www.druginfosys.com/Drug.aspx?DrugCode=1121&DrugName=Fluocortolone&type=1

Fluocortolone is a topical corticosteroid (class of steroid hormones formed in the adrenal gland). Is primary indicated in condition like, Ana fissure, Dermatosis haemorrhoids, proctitis. The signs and symptoms that are produced after the acute overdosage include convulsions, respiratory arrest, allergic skin reactions. Glucocorticoids, such as fluocortolone, act through nuclear hormone receptors Schaaf and Cidlowski (2002). The two members of this family are glucocorticoid receptor (GR) type I and GR type I I. Activation of these sites alters gene expression of endogenous agents that influence immune and inflammatory responses.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions
PubMed

PubMed

TitleDatePubMed
Contact allergies to topical corticosteroids: 10 cases of contact dermatitis.
1991 Aug
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
2001 Apr
Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.
2001 Jun
A case of cutaneous delayed-type allergy to oral dexamethasone and to betamethasone.
2002
Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis.
2003 Aug
[Bilateral uveitis intermedia. A 15-year clinical course].
2003 Dec
An integrative approach to eczema (atopic dermatitis).
2003 Jan-Feb
Childhood lichen planus with nail involvement: a case.
2003 Jul-Sep
Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids.
2003 Nov
Syphilitic interstitial keratitis: treatment with immunosuppressive drug combination therapy.
2004 Jul
Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
2004 Nov
Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study.
2005 Feb
Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
2006
An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty.
2006 Mar 15
[Sudden hearing loss in a patient with a 3-mm acoustic tumor].
2007
Varicella chorioretinitis.
2007 Dec
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).
2007 Jun
A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples.
2009 Apr
Adalimumab for the treatment of fistulas in patients with Crohn's disease.
2009 Jul
Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories.
2010 Apr
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
2010 Jan
Update on the management of chronic eczema: new approaches and emerging treatment options.
2010 Jul 28
Operational post-keratopasty graft tolerance due to differential HLAMatchmaker matching.
2010 Nov 11
Patents

Sample Use Guides

adult: 0.025 %; Frequency: 8 hours
Route of Administration: Topical
In Vitro Use Guide
Unknown
Name Type Language
FLUOCORTOLONE CAPROATE
MART.   USAN   WHO-DD  
USAN  
Official Name English
6.ALPHA.-FLUORO-11.BETA.-HYDROXY-21-HEXANOYLOXY-16.ALPHA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE
Systematic Name English
FLUOCORTOLONE 21-HEXANOATE
MI  
Common Name English
FLUOCORTOLONE CAPROATE [USAN]
Common Name English
FLUOCORTOLONE 21-HEXANOATE [MI]
Common Name English
SH-770
Code English
Fluocortolone caproate [WHO-DD]
Common Name English
FICOID
Brand Name English
FLUOCORTOLONE 21-CAPROATE
Common Name English
ULTRALANUM
Brand Name English
PREGNA-1,4-DIENE-3,20-DIONE, 6-FLUORO-11-HYDROXY-16-METHYL-21-((1-OXOHEXYL)OXY)-, (6.ALPHA.,11.BETA.,16.ALPHA.)-
Systematic Name English
FLUOCORTOLONE CAPROATE [MART.]
Common Name English
6α-Fluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-hexanoate
Systematic Name English
SH 770
Code English
FLUOCORTOLONE HEXANOATE
Common Name English
PREGNA-1,4-DIENE-3,20-DIONE, 6.ALPHA.-FLUORO-11.BETA.,21-DIHYDROXY-16.ALPHA.-METHYL-, 21-HEXANOATE
Systematic Name English
HEXANOIC ACID, 21-ESTER WITH 6.ALPHA.-FLUORO-11.BETA.,21-DIHYDROXY-16.ALPHA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE
Common Name English
Code System Code Type Description
ChEMBL
CHEMBL2107415
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
EPA CompTox
DTXSID30184387
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
EVMPD
SUB13901MIG
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
RXCUI
4464
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY RxNorm
EVMPD
SUB180207
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
SMS_ID
100000092391
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
NCI_THESAURUS
C171914
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
FDA UNII
90893P8662
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
MERCK INDEX
m5454
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
206-140-0
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
CAS
303-40-2
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
PUBCHEM
20054915
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY